Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis‐like T‐cell lymphoma
Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Weili Xue(First Affiliated Hospital of Zhengzhou University), Yingjun Wang(South China University of Technology), Xuefei Fu(Novogene Bioinformatics Institute), Wei Sun(Fred Hutch Cancer Center), Xin Li(North Sichuan Medical University), Xinhua Wang(Zhengzhou University), Lisha Lu(First Affiliated Hospital of Zhengzhou University), Guannan Wang(Harvard University), Lei Zhang(First Affiliated Hospital of Zhengzhou University), Jingjing Wu(Beijing Tian Tan Hospital), Jiaqin Yan(First Affiliated Hospital of Zhengzhou University), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Ling Li(Johns Hopkins University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Yu Chang(Jilin University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Feifei Nan(First Affiliated Hospital of Zhengzhou University), Zhi‐Yuan Zhou(Tsinghua University), Yajuan Qiu(Lymphoma Research Foundation), Mengyuan Jin(First Affiliated Hospital of Zhengzhou University)
Cited by 32
Related Papers
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
|Proceedings of the National Academy of Sciences|2011|644
Genetic Mechanisms of Immune Evasion in Colorectal Cancer
|Cancer Discovery|2018|558
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
|Cancer Cell|2018|251
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250